MedTrace Logo

Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses

NCT02956460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2018-04-02

Study results available
· View outcomes & findings →

Summary

Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1 month dispensing study (2 weeks each lens pair)

Conditions

  • Myopia

Interventions

DEVICE

fanfilcon A

contact lens

DEVICE

senofilcon A

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones, PhD, FAAO · Centre for Contact Lens Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-27
Primary Completion
2016-12-14
Completion
2016-12-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02956460 on ClinicalTrials.gov